CIK 0001659617
- Non-accelerated filer
- Smaller reporting company
Moleculin Biotech, Inc.
Sign in to watch- Ticker
- MBRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474671997
- Phone
- +1 713-300-5160
- Business address
- 5300 MEMORIAL DRIVE, SUITE 950, HOUSTON, TX, 77007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-07-11 | Climaco John M Director | Grant or award · Stock option (right to buy) | +35,000 | 105,000 | ||
| 2019-07-11 | PICKER DONALD H Chief Science Officer | Grant or award · Stock option (right to buy) | +100,000 | 235,000 | ||
| 2019-07-11 | Foster Jonathan P. Exec. Vice President and CFO | Grant or award · Stock option (right to buy) | +315,000 | 1,161,000 | ||
| 2019-05-22 | Climaco John M Director | Grant or award · Stock option (right to buy) | +15,000 | 70,000 | ||
| 2019-05-22 | CANNON MICHAEL D Director | Grant or award · Stock option (right to buy) | +15,000 | 85,000 | ||
| 2019-05-22 | George Robert E. Director | Grant or award · Stock option (right to buy) | +15,000 | 85,000 | ||
| 2018-06-06 | KLEMP WALTER V CEO and President | Grant or award · Stock option (right to buy) | +500,000 | 840,000 | ||
| 2018-06-06 | CANNON MICHAEL D Director | Grant or award · Stock option (right to buy) | +35,000 | 70,000 | ||
| 2018-06-06 | Climaco John M Director | Grant or award · Stock option (right to buy) | +35,000 | 55,000 | ||
| 2018-06-06 | PICKER DONALD H Chief Science Officer | Grant or award · Stock option (right to buy) | +75,000 | 135,000 | ||
| 2018-06-06 | George Robert E. Director | Grant or award · Stock option (right to buy) | +35,000 | 70,000 | ||
| 2018-06-06 | Foster Jonathan P. Chief Financial Officer | Grant or award · Stock option (right to buy) | +301,000 | 846,000 | ||
| 2018-06-06 | KLEMP WALTER V CEO and President | Grant or award · Stock option (right to buy) | +603,000 | 943,000 | ||
| 2017-10-03 | PICKER DONALD H Chief Science Officer | Grant or award · Stock option (right to buy) | +60,000 | 60,000 | ||
| 2017-10-03 | Foster Jonathan P. Chief Financial Officer | Grant or award · Stock option (right to buy) | +145,000 | 545,000 | ||
| 2017-10-03 | KLEMP WALTER V CEO | Grant or award · Stock option (right to buy) | +340,000 | 340,000 | ||
| 2017-08-16 | KLEMP WALTER V Chief Executive Officer | Sale | −100,000 | $1.70 | $170K | 967,724 |
| 2017-08-16 | Priebe Waldemar 10% owner | Sale | −100,000 | $1.70 | $170K | 2,781,573 |
| 2017-07-24 | CANNON MICHAEL D Director | Grant or award · Option to purchase common stock | +15,000 | 35,000 | ||
| 2017-07-24 | George Robert E. Director | Grant or award · Option to purchase common stock | +15,000 | 35,000 |
Page 13 of 14 · 269 trades